title: Changing the infection control paradigm from off-line to real time: the experience at Millard Fillmore Health System.
abstract: In 1993, several departments at Millard Fillmore Health System joined efforts to initiate a new approach to infection control. The main emphasis of this program is to move infection control to a real-time mode to manage patient outcomes daily. The principal objective was to decrease the number of nosocomial infections by 10%, with a particular emphasis on surgical-site infections. Besides real-time surveillance, we are critically evaluating several aspects of the management of nosocomial infections. High-level computer support has been the frame-work upon which this program was built. We have microcomputers that are linked directly to microbiology, pharmacy, billing, and admissions, downloading data several times daily. An expert software system merges all of the data, and from this we can target patients for real-time interventions. The computer system allows all inpatients to be screened for either infection control or antibiotic management interventions on a daily basis, with minimal time being spent on data collection and maximal efforts devoted to interventions at the bedside. Additionally, the infection management program will assist in maintaining the extraordinarily low expenditures on antimicrobial agents. During 1993, the Millard Fillmore Health System spent $924,884 on antibiotics, an amount approximately 50% that of comparably sized hospitals.
authors.affiliation: Department of Medicine, Millard Fillmore Health System, Buffalo, New York 14209, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Carr
authors.forename: P
authors.initials: P
authors.lastname: Fitzpatrick
authors.forename: J L
authors.initials: JL
authors.lastname: Izzo
authors.forename: T J
authors.initials: TJ
authors.lastname: Cumbo
authors.forename: M C
authors.initials: MC
authors.lastname: Birmingham
authors.forename: M H
authors.initials: MH
authors.lastname: Adelman
authors.forename: J A
authors.initials: JA
authors.lastname: Paladino
authors.forename: S C
authors.initials: SC
authors.lastname: Hanson
authors.forename: J J
authors.initials: JJ
authors.lastname: Schentag
mesh_terms: D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use*; D003199:Computer Systems; D003428:Cross Infection / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D016208:Databases, Factual; D003661:Decision Support Techniques; D004352:Drug Resistance, Microbial; D006751:Hospital Information Systems; D006801:Humans; D017053:Infection Control / Q000458:organization & administration*; D008329:Managed Care Programs / Q000458:organization & administration*; D009518:New York; D015397:Program Evaluation; D013530:Surgical Wound Infection / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control
chemical_list: D000900:Anti-Bacterial Agents